Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of nicotinic acetylcholine receptor modulators. It plays a role in creating compounds with potential applications in treating neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its structure supports binding affinity and selectivity for specific receptor subtypes, making it valuable in medicinal chemistry for optimizing drug candidates targeting cognitive and neurodegenerative conditions. Also utilized in research settings to explore structure-activity relationships in central nervous system-active agents.